Literature DB >> 22071292

Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas.

Maurilio Ponzoni1, Andrés J M Ferreri, Silvia Mappa, Elisa Pasini, Silvia Govi, Fabio Facchetti, Daniele Fanoni, Alessandra Tucci, Arianna Vino, Claudio Doglioni, Emilio Berti, Riccardo Dolcetti.   

Abstract

Borrelia burgdorferi has been variably associated with different forms of primary cutaneous lymphoma. Differences in prevalence rates among reported studies could be a result of geographic variability or heterogeneity in the molecular approaches that have been employed. In the present study, we investigated the prevalence of Borrelia burgdorferi sensu lato DNA in diagnostic tissue samples from fresh cutaneous biopsies of 98 primary cutaneous lymphomas and 19 normal skin controls. Three different polymerase chain reaction (PCR) protocols targeting the hbb, flagellin, and Osp-A genes were used. Direct sequencing of both sense and antisense strands of purified PCR products confirmed the specificity of the amplified fragments. Sequence specificity was assessed using the Basic Local Alignment Search Tool, and MultAlin software was used to investigate the heterogeneity of target gene sequences across the different samples. Borrelia DNA was not detected in 19 controls, 23 cases of follicular lymphoma, 31 cases of extranodal marginal zone lymphoma, or 30 cases of mycosis fungoides. A single case of 14 diffuse large B-cell lymphoma cases was positive for B. burgdorferi. This study does not support a pathogenic role of B. burgdorferi in primary cutaneous B- and T-cell lymphomas from areas nonendemic for this microorganism and the consequent rationale for the adoption of antibiotic therapy in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071292      PMCID: PMC3233293          DOI: 10.1634/theoncologist.2011-0108

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  23 in total

1.  Within European margins.

Authors:  Elisabeth Aberer; Volker Fingerle; Nora Wutte; Regina Fink-Puches; Lorenzo Cerroni
Journal:  Lancet       Date:  2011-01-08       Impact factor: 79.321

2.  Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association.

Authors:  Gaia Goteri; Renzo Ranaldi; Oriana Simonetti; Roberta Capretti; Stefano Menzo; Daniela Stramazzotti; Doriana Morichetti; Anna Maria Offidani; Serena Rupoli; Pietro Leoni
Journal:  Leuk Lymphoma       Date:  2007-11

3.  Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a.

Authors:  B Kütting; G Bonsmann; D Metze; T A Luger; L Cerroni
Journal:  J Am Acad Dermatol       Date:  1997-02       Impact factor: 11.527

4.  Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma.

Authors:  L Cerroni; N Zöchling; B Pütz; H Kerl
Journal:  J Cutan Pathol       Date:  1997-09       Impact factor: 1.587

5.  A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence.

Authors:  Denis Portnoï; Natacha Sertour; Elisabeth Ferquel; Martine Garnier; Guy Baranton; Danièle Postic
Journal:  FEMS Microbiol Lett       Date:  2006-06       Impact factor: 2.742

6.  Positive serology for Lyme disease borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding?

Authors:  S Jelić; I Filipović-Ljesković
Journal:  Hematol Oncol       Date:  1999-09       Impact factor: 5.271

7.  Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States.

Authors:  Hisashi Takino; Chunmei Li; Sindy Hu; Tseng-Tong Kuo; Eva Geissinger; Hans Konrad Muller-Hermelink; Bong Kim; Steven H Swerdlow; Hiroshi Inagaki
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

8.  An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types.

Authors:  H Michel; B Wilske; G Hettche; G Göttner; C Heimerl; U Reischl; U Schulte-Spechtel; V Fingerle
Journal:  Med Microbiol Immunol       Date:  2003-09-12       Impact factor: 3.402

Review 9.  Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

Authors:  Elise Olsen; Eric Vonderheid; Nicola Pimpinelli; Rein Willemze; Youn Kim; Robert Knobler; Herschel Zackheim; Madeleine Duvic; Teresa Estrach; Stanford Lamberg; Gary Wood; Reinhard Dummer; Annamari Ranki; Gunter Burg; Peter Heald; Mark Pittelkow; Maria-Grazia Bernengo; Wolfram Sterry; Liliane Laroche; Franz Trautinger; Sean Whittaker
Journal:  Blood       Date:  2007-05-31       Impact factor: 22.113

10.  Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?

Authors:  S Miertusova Tothova; S Bonin; G Trevisan; G Stanta
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more
  11 in total

Review 1.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

Review 2.  Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Authors:  Meenal Kheterpal; Neha Mehta-Shah; Pooja Virmani; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

Review 3.  Penicillin in Borrelia burgdorferi-negative Primary Cutaneous Marginal Zone Lymphoma: A Case Series and Literature Review.

Authors:  Yao Qin; Yang Wang
Journal:  Acta Derm Venereol       Date:  2022-03-14       Impact factor: 3.875

Review 4.  [Treatment of indolent cutaneous B‑cell lymphoma].

Authors:  M Wobser
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

Review 5.  The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas.

Authors:  Laahn H Foster; Craig A Portell
Journal:  Curr Treat Options Oncol       Date:  2015-06

Review 6.  Cutaneous primary B-cell lymphomas: from diagnosis to treatment.

Authors:  Margarida Lima
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

Review 7.  Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy.

Authors:  Salvatore Perrone; Gianna Maria D'Elia; Giorgia Annechini; Alessandro Pulsoni
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

Review 8.  Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.

Authors:  Max I Schreuder; Michiel van den Brand; Konnie M Hebeda; Patricia J T A Groenen; J Han van Krieken; Blanca Scheijen
Journal:  J Hematop       Date:  2017-09-25       Impact factor: 0.196

Review 9.  Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.

Authors:  Andreas Willerslev-Olsen; Thorbjørn Krejsgaard; Lise M Lindahl; Charlotte Menne Bonefeld; Mariusz A Wasik; Sergei B Koralov; Carsten Geisler; Mogens Kilian; Lars Iversen; Anders Woetmann; Niels Odum
Journal:  Toxins (Basel)       Date:  2013-08-14       Impact factor: 4.546

10.  Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.

Authors:  Katy Mastorci; Elena Muraro; Elisa Pasini; Chiara Furlan; Luca Sigalotti; Marina Cinco; Riccardo Dolcetti; Elisabetta Fratta
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.